Related Experiment Video
Updated: May 3, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Cardioembolic stroke diagnosis using blood biomarkers
Victor Llombart, Teresa Garcia-Berrocoso, Alejandro Bustamante
1Neurovascular Research Laboratory, Institut de Recerca Vall d'Hebron. Barcelona, Spain. Neurovascular Unit. Department of Neurology. Universitat Autonoma de Barcelona. Hospital Vall d'Hebron. Barcelona. Spain. llombs@hotmail.com.
Identifying specific biomarkers for cardioembolic stroke is crucial. This review explores protein, transcriptomic, and genetic markers, plus those linked to atrial fibrillation, to improve stroke diagnosis and treatment.
Area of Science:
- Neurology
- Cardiology
- Biomarker Discovery
Background:
- Stroke is a leading cause of death and disability globally.
- Cardioembolic strokes constitute a significant portion of ischemic strokes, with many cases remaining cryptogenic.
- Current diagnostic methods often fail to determine stroke etiology definitively.
Purpose of the Study:
- To provide an updated review of cardioembolic stroke-related biomarkers.
- To explore potential biomarkers at protein, transcriptomic, and genetic levels.
- To investigate biomarkers associated with atrial fibrillation for future cardioembolic stroke detection.
Main Methods:
- Literature review focusing on cardioembolic stroke biomarkers.
- Analysis of protein, transcriptomic, and genetic marker studies.
- Examination of biomarkers linked to atrial fibrillation.
Main Results:
- Several protein, transcriptomic, and genetic markers show potential for identifying cardioembolic stroke.
- Biomarkers associated with atrial fibrillation may serve as future indicators.
- Biomarker utilization could reduce cryptogenic stroke diagnoses.
Conclusions:
- Biomarkers offer a promising approach to complement diagnostics for cardioembolic stroke.
- Accurate etiological diagnosis aids in tailored treatment and recurrence prevention.
- Further research into these biomarkers is warranted for clinical application.
More Related Videos
11:03Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020
08:50Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
Published on: January 9, 2026
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Ischemic Stroke l: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests